Showing results (511-520 of 527) with videos related to
Sort By:
Pageof 53
The American Journal of Gastroenterology|May 2, 2020
Besifovir Dipivoxil Maleate 144-Week Treatment of Chronic Hepatitis B: An Open-Label Extensional Study of a Phase 3 TrialHyung Joon Yim, Won Kim, Sang Hoon Ahn, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 28, 2013
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: results from the randomized phase III BRISK-FL studyPhilip J Johnson, Shukui Qin, Joong-Won Park, et al.Medicine|April 9, 2016
An Observational, Multicenter, Cohort Study Evaluating the Antiviral Efficacy and Safety in Korean Patients With Chronic Hepatitis B Receiving Pegylated Interferon-alpha 2a (Pegasys): TRACES StudyYoung Eun Chon, Dong Joon Kim, Sang Gyune Kim, et al.BMC Medical Genetics|June 21, 2012
No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populationsHiromi Sawai, Nao Nishida, Hamdi Mbarek, et al.Alimentary Pharmacology & Therapeutics|May 27, 2020
Extremely low risk of hepatocellular carcinoma development in patients with chronic hepatitis B in immune-tolerant phaseHan Ah Lee, Hyun Woong Lee, In Hee Kim, et al.Clinical and Molecular Hepatology|January 25, 2021
Continuing besifovir dipivoxil maleate versus switching from tenofovir disoproxil fumarate for treatment of chronic hepatitis B: Results of 192-week phase 3 trialDo Seon Song, Won Kim, Sang Hoon Ahn, et al.Plos One|June 28, 2012
Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and KoreanNao Nishida, Hiromi Sawai, Kentaro Matsuura, et al.Journal of Hepatology|January 1, 2017
Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosisThomas Karlas, David Petroff, Magali Sasso, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 19, 2018
Efficacy and Safety of Besifovir Dipivoxil Maleate Compared With Tenofovir Disoproxil Fumarate in Treatment of Chronic Hepatitis B Virus InfectionSang Hoon Ahn, Won Kim, Young Kul Jung, et al.The American Journal of Gastroenterology|June 27, 2012
A prospective nationwide study of drug-induced liver injury in KoreaKi Tae Suk, Dong Joon Kim, Chang Hoon Kim, et al.Pageof 53